Novartis
-
Novartis Seeks FDA Approval for New COPD Drugs Following Successful Clinical Trials
-
Novartis Version of Neupogen Gets Favorable Review from FDA
-
Novartis Working on 'Fountain of Youth' Drug
-
Novartis Version of Amgen Cancer Drug Just as Good as Original
-
Acromegaly Drug Signifor by Novartis Receives EU Approval
-
Novartis drug LCZ696 for treating heart failure, promises to be a blockbuster
-
Experimental Novartis drug may reduce heart failure deaths, study reveals
-
New Novartis drug cuts heart failure mortality, hospital admission
-
Smart contact lens closer to reality, Novartis' Alcon unit signs agreement with Google
-
Google, Novartis team up to develop ‘smart’ contact lenses for diabetics
-
Google, Novartis set their sights on smart contact lens health care innovation
-
Novartis reports efficacy of Signifor LAR for acromegaly after Phase III trial
Most Popular
